These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. An update on the management of aspirin-exacerbated respiratory disease. Lee JH; Jung CG; Park HS Expert Rev Respir Med; 2018 Feb; 12(2):137-143. PubMed ID: 29249187 [TBL] [Abstract][Full Text] [Related]
8. State of the Art: Medical treatment of aspirin exacerbated respiratory disease (AERD). Ta V; Simon R Am J Rhinol Allergy; 2015; 29(1):41-3. PubMed ID: 25590318 [TBL] [Abstract][Full Text] [Related]
10. Aspirin-exacerbated respiratory disease: clinical disease and diagnosis. Bochenek G; Niżankowska-Mogilnicka E Immunol Allergy Clin North Am; 2013 May; 33(2):147-61. PubMed ID: 23639705 [TBL] [Abstract][Full Text] [Related]
11. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Berges-Gimeno MP; Simon RA; Stevenson DD Ann Allergy Asthma Immunol; 2002 Nov; 89(5):474-8. PubMed ID: 12452205 [TBL] [Abstract][Full Text] [Related]
12. Thromboxane A2 receptor +795T>C and chemoattractant receptor-homologous molecule expressed on Th2 cells -466T>C gene polymorphisms in patients with aspirin-exacerbated respiratory disease. Kohyama K; Hashimoto M; Abe S; Kodaira K; Yukawa T; Hozawa S; Morioka J; Inamura H; Yano M; Ota M; Sagara H; Kurosawa M Mol Med Rep; 2012 Feb; 5(2):477-82. PubMed ID: 22101342 [TBL] [Abstract][Full Text] [Related]
13. Fatty acid binding protein 1 is related with development of aspirin-exacerbated respiratory disease. Kim TH; Lee JY; Park JS; Park SW; Jang AS; Lee JY; Byun JY; Uh ST; Koh ES; Chung IY; Park CS PLoS One; 2011; 6(8):e22711. PubMed ID: 21829647 [TBL] [Abstract][Full Text] [Related]
14. Eosinophils and Mast Cells in Aspirin-Exacerbated Respiratory Disease. Steinke JW; Payne SC; Borish L Immunol Allergy Clin North Am; 2016 Nov; 36(4):719-734. PubMed ID: 27712766 [TBL] [Abstract][Full Text] [Related]
15. The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease. White AA; Stevenson DD; Simon RA Ann Allergy Asthma Immunol; 2005 Oct; 95(4):330-5. PubMed ID: 16279562 [TBL] [Abstract][Full Text] [Related]
16. Epithelial folliculin enhances airway inflammation in aspirin-exacerbated respiratory disease. Trinh HKT; Pham DL; Choi Y; Kim HM; Kim SH; Park HS Clin Exp Allergy; 2018 Nov; 48(11):1464-1473. PubMed ID: 30126026 [TBL] [Abstract][Full Text] [Related]
17. A possible association between ZNRD1 and aspirin-induced airway bronchoconstriction in a Korean population. Pasaje CF; Bae JS; Park BL; Cheong HS; Jang AS; Uh ST; Kim MK; Kim JH; Park TJ; Lee JS; Kim Y; Park CS; Shin HD J Investig Allergol Clin Immunol; 2012; 22(3):193-200. PubMed ID: 22697009 [TBL] [Abstract][Full Text] [Related]